Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial

BACKGROUND: Screening with low-dose computed tomography (LDCT) reduces lung cancer mortality; however, the most effective strategy for optimising participation is unknown. Here we present data from the Yorkshire Lung Screening Trial, including response to invitation, screening eligibility and uptake...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosbie, Philip A.J., Gabe, Rhian, Simmonds, Irene, Hancock, Neil, Alexandris, Panos, Kennedy, Martyn, Rogerson, Suzanne, Baldwin, David, Booton, Richard, Bradley, Claire, Darby, Mike, Eckert, Claire, Franks, Kevin N., Lindop, Jason, Janes, Sam M., Møller, Henrik, Murray, Rachael L., Neal, Richard D., Quaife, Samantha L., Upperton, Sara, Shinkins, Bethany, Tharmanathan, Puvan, Callister, Matthew E.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684623/
https://www.ncbi.nlm.nih.gov/pubmed/35777775
http://dx.doi.org/10.1183/13993003.00483-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684623/
https://www.ncbi.nlm.nih.gov/pubmed/35777775
http://dx.doi.org/10.1183/13993003.00483-2022

Ejemplares similares